Evidence map›Paper›PMID 26135870›Full record

ArticleJournal of clinical microbiology2015

Characterization of Third-Generation-Cephalosporin-Resistant Shiga Toxin-Producing Strains of Escherichia coli O157:H7 in Japan.

Ryuji Kawahara, Kazuko Seto, Masumi Taguchi, Chie Nakajima, Yuko Kumeda, Yasuhiko Suzuki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. First Isolation and Molecular Characterization ofFrontiers in veterinary science · 2021
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryuji KawaharaDivision of Bacteriology, Osaka Prefectural Institute of Public Health, Osaka, Japan kawahara@iph.pref.osaka.jp.
Kazuko SetoDivision of Bacteriology, Osaka Prefectural Institute of Public Health, Osaka, Japan.
Masumi TaguchiDivision of Bacteriology, Osaka Prefectural Institute of Public Health, Osaka, Japan.
Chie NakajimaDivision of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan Hokkaido University, The Global Station for Zoonosis Control, Sapporo, Japan.
Yuko KumedaDivision of Bacteriology, Osaka Prefectural Institute of Public Health, Osaka, Japan.
Yasuhiko SuzukiDivision of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan Hokkaido University, The Global Station for Zoonosis Control, Sapporo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We isolated Shiga toxin-producing Escherichia coli O157:H7 strains resistant to third-generation cephalosporins. The resistant strains harbored blaCMY-2, a plasmid-mediated AmpC β-lactamase. Genotyping of isolates revealed the possible spread of this problematic bacterium. Results suggested the importance of the investigation and surveillance of enterobacteria with plasmids harboring blaCMY-2.

Indexed as

beta-Lactam ResistanceAnti-Bacterial AgentsCephalosporinsEscherichia coli InfectionsEscherichia coli O157GenotypeHumansJapanPlasmidsShiga ToxinAnti-Bacterial AgentsCephalosporinsShiga Toxin

Identifiers

PMID26135870
PMCPMC4540945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.